Eisai EMEA
Nick Burgin is an experienced executive in the pharmaceutical industry, currently serving as President & COO and President of Global Value & Access at Eisai EMEA since April 2016. Burgin's tenure at Eisai Pharmaceuticals began in October 2010, where roles included President of the Global Value & Access Unit and various leadership positions focused on market access and regional management. Previous experience includes key roles at Eisai, Eisai Ltd, Altana Pharma, Pharmacia, and GD Searle, with a strong background in sales, marketing, and business development spanning over two decades.
This person is not in any offices
Eisai EMEA
3 followers
At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries. Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology. Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do. For more information about Eisai in the EMEA region please visit www.eisai.eu Our community guidelines can be found here: https://www.eisai.eu/wp-content/uploads/Community-guidelines-v1.0.pdf For more information about how Eisai processes your data, please refer to our privacy policy here: https://www.eisai.eu/privacy-policy/ --- November 2023 | EMEA-NON-23-00180